Aspiriant LLC’s iShares MSCI EAFE Small-Cap ETF SCZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62M Sell
46,145
-6,738
-13% -$548K 0.1% 83
2025
Q4
$4.1M Sell
52,883
-4,530
-8% -$347K 0.12% 80
2025
Q3
$4.4M Sell
57,413
-737
-1% -$55.1K 0.13% 71
2025
Q2
$4.23M Buy
58,150
+890
+2% +$60.2K 0.13% 71
2025
Q1
$3.64M Hold
57,260
0.13% 63
2024
Q4
$3.48M Buy
57,260
+71
+0.1% +$4.52K 0.13% 70
2024
Q3
$3.87M Sell
57,189
-1,738
-3% -$112K 0.15% 64
2024
Q2
$3.63M Sell
58,927
-167
-0.3% -$10.5K 0.15% 65
2024
Q1
$3.74M Buy
59,094
+1,320
+2% +$80.7K 0.15% 63
2023
Q4
$3.58M Sell
57,774
-221
-0.4% -$12.6K 0.16% 63
2023
Q3
$3.28M Sell
57,995
-82
-0.1% -$4.84K 0.17% 65
2023
Q2
$3.43M Sell
58,077
-2,674
-4% -$160K 0.17% 63
2023
Q1
$3.62M Buy
60,751
+2,060
+4% +$122K 0.19% 60
2022
Q4
$3.31M Sell
58,691
-5,192
-8% -$279K 0.17% 65
2022
Q3
$3.11M Sell
63,883
-10,933
-15% -$600K 0.15% 62
2022
Q2
$4.09M Buy
74,816
+3,541
+5% +$214K 0.2% 59
2022
Q1
$4.73M Buy
71,275
+5,167
+8% +$351K 0.26% 53
2021
Q4
$4.83M Sell
66,108
-1,018
-2% -$75.6K 0.26% 52
2021
Q3
$4.99M Buy
67,126
+2,612
+4% +$199K 0.29% 43
2021
Q2
$4.79M Buy
64,514
+14,344
+29% +$1.08M 0.27% 40
2021
Q1
$3.6M Sell
50,170
-1,037
-2% -$73.6K 0.23% 43
2020
Q4
$3.5M Sell
51,207
-1,179
-2% -$74.4K 0.24% 43
2020
Q3
$3.09M Sell
52,386
-617
-1% -$35.4K 0.24% 51
2020
Q2
$2.84M Buy
53,003
+26,580
+101% +$1.34M 0.26% 44
2020
Q1
$1.18M Buy
26,423
+16,831
+175% +$935K 0.12% 71
2019
Q4
$598K Sell
9,592
-488
-5% -$29.3K 0.06% 124
2019
Q3
$578K Buy
10,080
+978
+11% +$55.3K 0.05% 133
2019
Q2
$522K Sell
9,102
-668
-7% -$38.6K 0.04% 145
2019
Q1
$561K Sell
9,770
-13,783
-59% -$772K 0.05% 139
2018
Q4
$1.22M Buy
+23,553
New +$1.32M 0.09% 97
2016
Q2
Sell
-5,765
Closed -$287K 189
2016
Q1
$287K Hold
5,765
0.03% 153
2015
Q4
$288K Sell
5,765
-7,831
-58% -$391K 0.03% 69
2015
Q3
$675K Sell
13,596
-2,066
-13% -$103K 0.06% 61
2015
Q2
$799K Buy
15,662
+9,687
+162% +$505K 0.08% 56
2015
Q1
$296K Sell
5,975
-1,610
-21% -$77.8K 0.04% 74
2014
Q4
$354K Sell
7,585
-3,129
-29% -$148K 0.05% 67
2014
Q3
$520K Sell
10,714
-8,989
-46% -$459K 0.07% 54
2014
Q2
$1.04M Hold
19,703
0.14% 43
2014
Q1
$1.03M Buy
19,703
+2,920
+17% +$150K 0.15% 49
2013
Q4
$856K Buy
16,783
+991
+6% +$49.1K 0.13% 44
2013
Q3
$766K Buy
15,792
+1,668
+12% +$76.6K 0.14% 30
2013
Q2
$592K Buy
+14,124
New +$625K 0.09% 43

Other funds holding SCZ

Aspiriant LLC's SCZ Position: Q1 2026 in Review

Aspiriant LLC reduced its iShares MSCI EAFE Small-Cap ETF (SCZ) stake by 13% in Q1 2026, selling an estimated $548K and leaving 46,145 shares worth $3.62M. The position accounts for 0.1% of the portfolio, ranked #83.

Aspiriant LLC first reported a position in SCZ in Q2 2013 and has held it in 42 quarters since. The position peaked at $4.99M in Q3 2021. 758 funds tracked by Wall St. Rank hold SCZ as of Q1 2026.

  • Aspiriant LLC held 46,145 shares of iShares MSCI EAFE Small-Cap ETF worth $3.62M as of Q1 2026.
  • Aspiriant LLC sold 6,738 iShares MSCI EAFE Small-Cap ETF shares in Q1 2026, an estimated $548K.
  • iShares MSCI EAFE Small-Cap ETF made up 0.1% of Aspiriant LLC's portfolio in Q1 2026, its #83 holding.
  • Aspiriant LLC first reported a position in iShares MSCI EAFE Small-Cap ETF in Q2 2013 and has held it in 42 quarters since.
  • Aspiriant LLC's iShares MSCI EAFE Small-Cap ETF position peaked at $4.99M in Q3 2021.
  • 758 funds tracked by Wall St. Rank held iShares MSCI EAFE Small-Cap ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.